A Clinical Study on the Application of Hyperbaric Oxygen Therapy in Hand Surgery Trauma

Background: Traumatic injuries to the hand, including crush injuries, avulsions, devascularizations, and complex fractures with soft tissue compromise, present significant surgical challenges due to compromised tissue perfusion, edema, and high risk of infection and necrosis. Hyperbaric Oxygen Therapy (HBOT), which involves breathing 100% oxygen at pressures greater than one atmosphere absolute (ATA), is an adjunctive treatment proposed to enhance wound healing in such complex scenarios by maximizing tissue oxygenation. Objective: This study aimed to evaluate the clinical efficacy and outcomes of adjunctive HBOT in the management of acute traumatic hand injuries requiring surgical intervention. Methods: A prospective, randomized controlled trial was conducted involving 80 patients with severe traumatic hand injuries (Gustilo Anderson type IIIB/C open fractures, severe crush injuries with devitalized tissue, or replantation/revascularization cases). Patients were randomly assigned to the Standard Care Group (n=40), receiving surgical management (debridement, fixation, vascular repair, flap coverage as needed) and conventional post operative care, or the HBOT Group (n=40), receiving standard surgical care plus an adjunctive HBOT protocol (2.4 ATA for 90 minutes, twice daily for 5 days, then once daily for a total of 20 30 sessions). Primary outcomes included wound healing rate, time to complete wound closure/graft take, flap survival rate, and infection rate. Secondary outcomes encompassed functional recovery (Total Active Motion   TAM, grip strength), analgesic requirement, and length of hospital stay. Results: The HBOT group demonstrated statistically superior outcomes. The incidence of major post operative complications (flap/graft failure, deep infection, osteomyelitis) was significantly lower (15% vs. 37.5% in the control group, p<0.05). Time to complete wound closure or successful graft/flap take was reduced by an average of 4.2 days (p<0.01). Flap survival rates were 94% in the HBOT group compared to 82% in controls (p<0.05). Functionally, the HBOT group showed significantly greater TAM recovery at 3 month follow up (p<0.01) and required fewer opioid analgesics in the first post operative week (p<0.05). Conclusion: Adjunctive HBOT significantly improves wound healing, reduces complication rates, and enhances functional recovery in patients with severe traumatic hand injuries. It serves as a valuable adjuvant to meticulous surgical technique by modulating the ischemic reperfusion injury, controlling edema, and augmenting neovascularization, thereby optimizing conditions for tissue survival and repair.